Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +2.31% | -6.99% | -27.72% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
Financials (USD)
Sales 2024 * | 66.77M | Sales 2025 * | 82.57M | Capitalization | 189M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -38M | EV / Sales 2024 * | 2.83 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
-3.56
x | P/E ratio 2025 * |
-4.99
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.9% |
Latest transcript on Biodesix, Inc.
1 day | +2.31% | ||
1 week | -6.99% | ||
Current month | -6.99% | ||
1 month | -14.19% | ||
3 months | -11.33% | ||
6 months | -16.35% | ||
Current year | -27.72% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.33 | +2.31% | 94,636 |
24-06-06 | 1.3 | -5.11% | 43,807 |
24-06-05 | 1.37 | +3.79% | 174,229 |
24-06-04 | 1.32 | -1.49% | 44,635 |
24-06-03 | 1.34 | -6.29% | 55,014 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.72% | 193M | |
-22.13% | 7.9B | |
+76.16% | 4.53B | |
+8.56% | 2.78B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-19.59% | 1.66B | |
-20.07% | 1.49B | |
+19.31% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- BDSX Stock